1. Home
  2. PODD vs GFS Comparison

PODD vs GFS Comparison

Compare PODD & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • GFS
  • Stock Information
  • Founded
  • PODD 2000
  • GFS 2009
  • Country
  • PODD United States
  • GFS United States
  • Employees
  • PODD N/A
  • GFS N/A
  • Industry
  • PODD Medical/Dental Instruments
  • GFS Semiconductors
  • Sector
  • PODD Health Care
  • GFS Technology
  • Exchange
  • PODD Nasdaq
  • GFS Nasdaq
  • Market Cap
  • PODD 22.1B
  • GFS 18.5B
  • IPO Year
  • PODD 2007
  • GFS 2021
  • Fundamental
  • Price
  • PODD $311.95
  • GFS $36.06
  • Analyst Decision
  • PODD Strong Buy
  • GFS Buy
  • Analyst Count
  • PODD 19
  • GFS 13
  • Target Price
  • PODD $338.79
  • GFS $44.15
  • AVG Volume (30 Days)
  • PODD 461.0K
  • GFS 2.8M
  • Earning Date
  • PODD 11-06-2025
  • GFS 11-12-2025
  • Dividend Yield
  • PODD N/A
  • GFS N/A
  • EPS Growth
  • PODD N/A
  • GFS N/A
  • EPS
  • PODD 3.32
  • GFS N/A
  • Revenue
  • PODD $2,359,500,000.00
  • GFS $6,842,000,000.00
  • Revenue This Year
  • PODD $29.27
  • GFS $1.02
  • Revenue Next Year
  • PODD $18.30
  • GFS $8.29
  • P/E Ratio
  • PODD $95.15
  • GFS N/A
  • Revenue Growth
  • PODD 26.00
  • GFS N/A
  • 52 Week Low
  • PODD $227.03
  • GFS $29.77
  • 52 Week High
  • PODD $353.50
  • GFS $47.69
  • Technical
  • Relative Strength Index (RSI)
  • PODD 41.83
  • GFS 56.78
  • Support Level
  • PODD $320.76
  • GFS $34.08
  • Resistance Level
  • PODD $326.81
  • GFS $36.20
  • Average True Range (ATR)
  • PODD 7.35
  • GFS 1.25
  • MACD
  • PODD -0.26
  • GFS 0.01
  • Stochastic Oscillator
  • PODD 1.89
  • GFS 70.81

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About GFS GlobalFoundries Inc.

GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and employs about 13,000 people.

Share on Social Networks: